Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HIG9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 203 | 207 | PF00656 | 0.469 |
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.587 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.490 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.653 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.539 |
CLV_PCSK_FUR_1 | 20 | 24 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.624 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.653 |
CLV_PCSK_PC1ET2_1 | 231 | 233 | PF00082 | 0.624 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.534 |
DOC_CYCLIN_RxL_1 | 19 | 28 | PF00134 | 0.365 |
DOC_PP1_RVXF_1 | 33 | 39 | PF00149 | 0.471 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.653 |
LIG_14-3-3_CanoR_1 | 124 | 128 | PF00244 | 0.599 |
LIG_14-3-3_CanoR_1 | 199 | 205 | PF00244 | 0.704 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 261 | 269 | PF00244 | 0.441 |
LIG_14-3-3_CanoR_1 | 84 | 94 | PF00244 | 0.477 |
LIG_14-3-3_CterR_2 | 296 | 300 | PF00244 | 0.536 |
LIG_Actin_WH2_2 | 194 | 212 | PF00022 | 0.442 |
LIG_Actin_WH2_2 | 72 | 88 | PF00022 | 0.540 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.706 |
LIG_Clathr_ClatBox_1 | 149 | 153 | PF01394 | 0.367 |
LIG_FHA_1 | 144 | 150 | PF00498 | 0.350 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.323 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.487 |
LIG_FHA_2 | 153 | 159 | PF00498 | 0.613 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.456 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.538 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.533 |
LIG_LIR_Gen_1 | 275 | 283 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 275 | 279 | PF02991 | 0.432 |
LIG_SUMO_SIM_anti_2 | 143 | 151 | PF11976 | 0.504 |
LIG_SUMO_SIM_anti_2 | 5 | 13 | PF11976 | 0.601 |
LIG_SUMO_SIM_anti_2 | 62 | 70 | PF11976 | 0.607 |
LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.632 |
LIG_TRAF2_1 | 225 | 228 | PF00917 | 0.606 |
LIG_TRAF2_1 | 88 | 91 | PF00917 | 0.369 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.564 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.523 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.573 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.495 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.495 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.711 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.633 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.652 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.633 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.398 |
MOD_GlcNHglycan | 5 | 9 | PF01048 | 0.593 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.608 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.597 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.496 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.525 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.584 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.657 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.608 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.454 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.578 |
MOD_PIKK_1 | 235 | 241 | PF00454 | 0.424 |
MOD_PIKK_1 | 25 | 31 | PF00454 | 0.602 |
MOD_PIKK_1 | 85 | 91 | PF00454 | 0.621 |
MOD_PKA_2 | 104 | 110 | PF00069 | 0.455 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.587 |
MOD_PKA_2 | 204 | 210 | PF00069 | 0.474 |
MOD_PKA_2 | 260 | 266 | PF00069 | 0.388 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.473 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.612 |
MOD_Plk_1 | 4 | 10 | PF00069 | 0.518 |
MOD_Plk_2-3 | 153 | 159 | PF00069 | 0.360 |
MOD_SUMO_for_1 | 150 | 153 | PF00179 | 0.552 |
MOD_SUMO_rev_2 | 227 | 233 | PF00179 | 0.629 |
MOD_SUMO_rev_2 | 28 | 37 | PF00179 | 0.583 |
TRG_DiLeu_BaEn_1 | 145 | 150 | PF01217 | 0.533 |
TRG_DiLeu_BaEn_1 | 42 | 47 | PF01217 | 0.579 |
TRG_DiLeu_BaLyEn_6 | 20 | 25 | PF01217 | 0.377 |
TRG_ER_diArg_1 | 123 | 125 | PF00400 | 0.589 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDE9 | Leptomonas seymouri | 45% | 96% |
A0A1X0P1M8 | Trypanosomatidae | 29% | 100% |
A0A3S7X3N1 | Leishmania donovani | 78% | 100% |
A0A422NW57 | Trypanosoma rangeli | 28% | 100% |
A4I5R6 | Leishmania infantum | 78% | 100% |
C9ZR34 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9B111 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q4Q755 | Leishmania major | 77% | 100% |
V5BGW1 | Trypanosoma cruzi | 32% | 100% |